reference/30224065

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30224065

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	386
issn	1468-2060 0003-4967
issueIdentifier	2
pageRange	380-386
publicationName	Annals of the Rheumatic Diseases
startingPage	380
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_01ce0ec97a99fb421b40fff6ca0c078e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a61b14779b6f91b125e7274e47d3e0bb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_21abac2d05d4984a1bb22fd879ba0e03
bibliographicCitation	Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, Bishai W, Hochberg MC; CORRONA Investigators. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis. 2010 Feb;69(2):380–6. PMID: 19359261; PMCID: PMC2861900.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bda2a8f2132cec8f8d324e553c60940c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d4ccbab2b0a4fb8aaf05ae43304af0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61916fd4c7c5c8487dcaaba54e70fd1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_341cce0a3771c1c6ebefb6664f9d3885 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_101a567b998f37154d0b23e097379316 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73aa67937f60389f8329dde8aa37b955 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_938fbb162b00c8bafafc4a6ec7a9dc14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_604f878b2c0fef431c11a37a9aa09f33
date	2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2861900 https://pubmed.ncbi.nlm.nih.gov/19359261 https://doi.org/10.1136/ard.2008.089276
isPartOf	https://portal.issn.org/resource/ISSN/0003-4967 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640 https://portal.issn.org/resource/ISSN/1468-2060
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
discusses	http://id.nlm.nih.gov/mesh/M0022150 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0009322 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014409Q000037 http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D018501Q000009 http://id.nlm.nih.gov/mesh/D007239Q000139 http://id.nlm.nih.gov/mesh/D008727Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001172Q000453 http://id.nlm.nih.gov/mesh/D007239Q000453 http://id.nlm.nih.gov/mesh/D001172Q000150 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007239Q000150 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005938Q000009 http://id.nlm.nih.gov/mesh/D009894Q000453 http://id.nlm.nih.gov/mesh/D009894Q000150 http://id.nlm.nih.gov/mesh/D011241Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009894Q000139 http://id.nlm.nih.gov/mesh/D007166Q000009 http://id.nlm.nih.gov/mesh/D004812 http://id.nlm.nih.gov/mesh/D004359
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2254 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 70.